• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE Back to Search Results
Model Number N/A
Device Problem Inaccurate Delivery (2339)
Patient Problems Hyperglycemia (1905); Diabetic Ketoacidosis (2364)
Event Type  Injury  
Event Description
Event verbatim [preferred term] (related symptoms if any separated by commas) had acetone in his blood [blood ketone body increased] hyperglycemia [hyperglycaemia] after pressing the dose counter the pen doesn't inject all the insulin amounts [device delivery system issue] case description: this serious spontaneous case from egypt was reported by a patient family member or friend as "had acetone in his blood(blood ketone body increased)" with an unspecified onset date, "hyperglycemia(hyperglycemia)" with an unspecified onset date, "after pressing the dose counter the pen doesn't inject all the insulin amounts(inaccurate delivery by device)" with an unspecified onset date, and concerned a male patient who was treated with novopen 4 (insulin delivery device) from unknown start date for "device therapy", novorapid penfill (insulin aspart) (dose, frequency & route used-unk) from unknown start date for "diabetes mellitus".Patient height, weight and body mass index not mentioned current condition: diabetes mellitus.(type and duration not mentioned) on an unknown date the patient had suffered from hyperglycemia and had acetone in his blood due to the technical problem of patients novopen 4 ( using novorapid penfill ), after pressing the dose counter the pen doesn't inject all the insulin amounts pen training was offered but the patient refused to perform the steps batch numbers: novopen 4: lvg5b14 novorapid penfill: was requested action taken to novorapid penfill was not reported.The outcome for the event "had acetone in his blood(blood ketone body increased)" was not reported.The outcome for the event "hyperglycemia(hyperglycemia)" was not reported.The outcome for the event "after pressing the dose counter the pen doesn't inject all the insulin amounts(inaccurate delivery by device)" was not reported.Preliminary manufacturer's comment: (b)(6) 2023: the suspected device novopen 4 has not been returned for evaluation.No conclusion is reached.
 
Event Description
Case description: investigation results: novopen 4, batch number: lvg5b14.The product was not returned for examination.Since last submission the case has been updated with the following: imdrf codes and investigation results added, relevant fields in eu/ca tab updated, narrative was updated accordingly.Final manufacturer's comment: 16-may-2023: the suspected device novopen 4 has not been returned for evaluation.The batch trend analysis and reference sample examination revealed nothing abnormal.No abnormalities relating to the observed problem were found.With the available limited information regarding the handling of the suspected device, it is not possible to identify a clear root cause in relation to functionality of novopen 4.Events are listed.This single case report is not considered to change the current knowledge of the safety profile of novorapid penfill.H3 continued: evaluation summary: novopen 4, batch number: lvg5b14.The product was not returned for examination.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOPEN 4
Type of Device
INSULIN DELIVERY DEVICE
Manufacturer (Section D)
NOVO NORDISK A/S, MEDICAL SYSTEMS
hilleroed,,
DA 
Manufacturer (Section G)
NOVO NORDISK A/S, MEDICAL SYSTEMS
brennum park
hilleroed,, 3400
DA   3400
Manufacturer Contact
p.o. box 846
plainsboro, NJ 08536
8007276500
MDR Report Key16782860
MDR Text Key313707513
Report Number9681821-2023-00058
Device Sequence Number1
Product Code FMF
Combination Product (y/n)Y
Reporter Country CodeEG
PMA/PMN Number
20-986
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Model NumberN/A
Device Catalogue Number185490
Device Lot NumberLVG5B14
Was Device Available for Evaluation? No
Date Manufacturer Received05/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/20/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexMale
-
-